[et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” use_background_color_gradient=”on” background_color_gradient_stops=”#e02b20 0%|#a01414 100%” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” _builder_version=”4.27.4″ _module_preset=”default” custom_padding_tablet=”” custom_padding_phone=”||12px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”programs” _builder_version=”4.27.4″ _module_preset=”default” title_font=”|800||on|||||” title_text_align=”center” title_text_color=”#FFFFFF” title_font_size=”50px” custom_margin_tablet=”” custom_margin_phone=”30px||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”||||false|false” title_font_size_tablet=”50px” title_font_size_phone=”33px” title_font_size_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”guid” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_heading title=”Clinical Guidelines” _builder_version=”4.27.4″ _module_preset=”default” title_font=”|700|||||||” title_text_align=”center” title_text_color=”#000000″ title_font_size=”41px” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”3_5,2_5″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”3_5″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_heading title=”Clinical Practice Guidelines for the Management of Hyperglycemia in Pregnancy (HIP): An Expert Consensus Statement from the Libyan Diabetes Association (LDA):” _builder_version=”4.27.4″ _module_preset=”default” title_font=”|700|||||||” title_text_color=”#E02B20″ title_line_height=”1.1em” title_font_size_tablet=”” title_font_size_phone=”21px” title_font_size_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n
The National Guideline for Diabetes in Pregnancy 2025<\/em> is a comprehensive document issued by the Libyan Diabetes Association. It provides clinical recommendations for the diagnosis, management, and prevention of diabetes during pregnancy, aiming to unify medical practices across Libya. The guideline addresses both pre-existing diabetes<\/strong> and gestational diabetes (GDM)<\/strong>, highlighting their significant impact on maternal and neonatal health. It emphasizes the risks of complications such as preeclampsia<\/strong>, stillbirth<\/strong>, and hypertension<\/strong>, as well as long-term health risks for both mother and child.<\/p>\n Overall, the guideline aims to improve pregnancy outcomes, promote standardized clinical practices, and enhance the quality of maternal healthcare services in Libya.<\/p>\n [\/et_pb_text][et_pb_button button_url=”https:\/\/lda.ly\/wp-content\/uploads\/2025\/10\/LMJ-17326.pdf” button_text=”Read ” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_color=”#E02B20″ global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_button][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]Download Link<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=”2_5″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_image src=”https:\/\/lda.ly\/wp-content\/uploads\/2025\/10\/\u0644\u0642\u0637\u0629-\u0627\u0644\u0634\u0627\u0634\u0629-2025-10-27-113333.png” title_text=”\u0644\u0642\u0637\u0629 \u0627\u0644\u0634\u0627\u0634\u0629 2025-10-27 113333″ align=”center” align_tablet=”center” align_phone=”center” align_last_edited=”on|desktop” _builder_version=”4.27.4″ _module_preset=”default” border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset6″ global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ theme_builder_area=”post_content” _builder_version=”4.27.4″ _module_preset=”default”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” theme_builder_area=”post_content” column_structure=”1_2,1_2″][et_pb_column _builder_version=”4.27.4″ _module_preset=”default” type=”1_2″ theme_builder_area=”post_content”][et_pb_image src=”https:\/\/lda.ly\/wp-content\/uploads\/2025\/10\/\u0644\u0642\u0637\u0629-\u0627\u0644\u0634\u0627\u0634\u0629-2025-10-27-110930.png” title_text=”\u0644\u0642\u0637\u0629 \u0627\u0644\u0634\u0627\u0634\u0629 2025-10-27 110930″ align=”center” align_tablet=”center” align_phone=”center” align_last_edited=”on|desktop” _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ border_radii=”on|10px|10px|10px|10px” box_shadow_style=”preset6″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″][\/et_pb_image][\/et_pb_column][et_pb_column _builder_version=”4.27.4″ _module_preset=”default” type=”1_2″ theme_builder_area=”post_content”][et_pb_heading title=”Clinical Practice Guidelines for the Management of Hyperglycemia in Pregnancy (HIP): An Expert Consensus Statement from the Libyan Diabetes Association (LDA):” _builder_version=”4.27.4″ _module_preset=”default” title_font=”|700|||||||” title_text_color=”#E02B20″ title_line_height=”1.1em” title_font_size_tablet=”” title_font_size_phone=”21px” title_font_size_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”][\/et_pb_heading][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content” custom_margin=”||7px|||” custom_padding=”||14px|||”]<\/p>\n The National Guideline for Diabetes in Pregnancy 2025<\/em> is a comprehensive document issued by the Libyan Diabetes Association. It provides clinical recommendations for the diagnosis, management, and prevention of diabetes during pregnancy, aiming to unify medical practices across Libya. The guideline addresses both pre-existing diabetes<\/strong> and gestational diabetes (GDM)<\/strong>, highlighting their significant impact on maternal and neonatal health. It emphasizes the risks of complications such as preeclampsia<\/strong>, stillbirth<\/strong>, and hypertension<\/strong>, as well as long-term health risks for both mother and child.<\/p>\n Overall, the guideline aims to improve pregnancy outcomes, promote standardized clinical practices, and enhance the quality of maternal healthcare services in Libya.<\/p>\n [\/et_pb_text][et_pb_heading title=”Notice:” _builder_version=”4.27.4″ _module_preset=”default” theme_builder_area=”post_content” background_color=”#E02B20″ custom_padding=”10px|||10px|false|false” title_level=”h4″ border_radii=”on|10px|10px|10px|10px” title_text_color=”#FFFFFF” hover_enabled=”0″ sticky_enabled=”0″][\/et_pb_heading][et_pb_button button_url=”https:\/\/lda.ly\/wp-content\/uploads\/2025\/10\/\u0627\u0644\u0643\u062a\u064a\u0628-\u0642\u0631\u0627\u0621\u0629.pdf” button_text=”Read ” _builder_version=”4.27.4″ _module_preset=”default” custom_button=”on” button_text_color=”#E02B20″ hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″][\/et_pb_button][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]Download Link<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" The National Guideline for Diabetes in Pregnancy 2025 is a comprehensive document issued by the Libyan Diabetes Association. It provides clinical recommendations for the diagnosis, management, and prevention of diabetes during pregnancy, aiming to unify medical practices across Libya. The guideline addresses both pre-existing diabetes and gestational diabetes (GDM), highlighting their significant impact on maternal […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-458","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/pages\/458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/comments?post=458"}],"version-history":[{"count":3,"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/pages\/458\/revisions"}],"predecessor-version":[{"id":463,"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/pages\/458\/revisions\/463"}],"wp:attachment":[{"href":"https:\/\/lda.ly\/index.php\/wp-json\/wp\/v2\/media?parent=458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}